KYMERA THERAPEUTICS, INC. Variable Lease, Cost
KYMERA THERAPEUTICS, INC. (KYMR) reported Variable Lease, Cost of $1.45 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-08-05
- KYMERA THERAPEUTICS, INC. variable lease, cost for the quarter ending 2026-06-30 was $1.45M, a 6.45% decline year-over-year.
- KYMERA THERAPEUTICS, INC. variable lease, cost for the quarter ending 2026-03-31 was $1.37M, a 8.03% decline year-over-year.
- KYMERA THERAPEUTICS, INC. variable lease, cost for the quarter ending 2025-12-31 was $1.53M, a 42.79% increase year-over-year.
- KYMERA THERAPEUTICS, INC. variable lease, cost for the quarter ending 2025-09-30 was $1.46M, a 2.89% increase year-over-year.
- KYMERA THERAPEUTICS, INC. variable lease, cost for fiscal 2025 was $6.04M, a 18.76% increase from fiscal 2024.
- KYMERA THERAPEUTICS, INC. variable lease, cost for fiscal 2024 was $5.09M, a 435.93% increase from fiscal 2023.
- KYMERA THERAPEUTICS, INC. variable lease, cost for fiscal 2023 was $949.00K, a 20.39% decline from fiscal 2022.
- KYMERA THERAPEUTICS, INC. variable lease, cost for fiscal 2022 was $1.19M, a 17.44% increase from fiscal 2021.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month | Variable Lease, Cost 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.45M 10-Q · filed 2026-08-05 | $2.82M 10-Q · filed 2026-08-05 | $4.36M derived: sum of 3 quarters · filed 2026-08-05 | $5.82M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $1.37M 10-Q · filed 2026-04-30 | $2.91M derived: sum of 2 quarters · filed 2026-04-30 | $4.37M derived: sum of 3 quarters · filed 2026-04-30 | $5.92M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $1.53M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $3.00M derived: sum of 2 quarters · filed 2026-02-26 | $4.55M derived: sum of 3 quarters · filed 2026-08-05 | $6.04M 10-K · filed 2026-02-26 |
| 2025-09-30 | $1.46M 10-Q · filed 2025-11-04 | $3.01M derived: sum of 2 quarters · filed 2026-08-05 | $4.50M 10-Q · filed 2025-11-04 | $5.58M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $1.55M 10-Q · filed 2026-08-05 | $3.04M 10-Q · filed 2026-08-05 | $4.12M derived: sum of 3 quarters · filed 2026-08-05 | $5.54M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $1.49M 10-Q · filed 2026-04-30 | $2.57M derived: sum of 2 quarters · filed 2026-04-30 | $3.99M derived: sum of 3 quarters · filed 2026-04-30 | $5.38M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $1.07M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.50M derived: sum of 2 quarters · filed 2026-02-26 | $3.88M derived: sum of 3 quarters · filed 2026-02-26 | $5.09M 10-K · filed 2026-02-26 |
| 2024-09-30 | $1.42M 10-Q · filed 2025-11-04 | $2.81M derived: sum of 2 quarters · filed 2025-11-04 | $4.01M 10-Q · filed 2025-11-04 | $4.25M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $1.39M 10-Q · filed 2025-08-11 | $2.59M 10-Q · filed 2025-08-11 | $2.83M derived: sum of 3 quarters · filed 2025-08-11 | $3.10M derived: sum of 4 quarters · filed 2025-08-11 |
| 2024-03-31 | $1.20M 10-Q · filed 2025-05-09 | $1.44M derived: sum of 2 quarters · filed 2025-05-09 | $1.71M derived: sum of 3 quarters · filed 2025-05-09 | $1.93M derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | $237.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $510.00K derived: sum of 2 quarters · filed 2025-02-27 | $730.00K derived: sum of 3 quarters · filed 2025-02-27 | $949.00K 10-K · filed 2025-02-27 |
| 2023-09-30 | $273.00K 10-Q · filed 2024-10-31 | $493.00K derived: sum of 2 quarters · filed 2024-10-31 | $712.00K 10-Q · filed 2024-10-31 | $1.03M derived: sum of 4 quarters · filed 2024-10-31 |
| 2023-06-30 | $220.00K 10-Q · filed 2024-08-07 | $440.00K 10-Q · filed 2024-08-07 | $762.00K derived: sum of 3 quarters · filed 2024-08-07 | $1.06M derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | $220.00K 10-Q · filed 2024-05-02 | $542.00K derived: sum of 2 quarters · filed 2024-05-02 | $839.00K derived: sum of 3 quarters · filed 2024-05-02 | $1.08M derived: sum of 4 quarters · filed 2024-05-02 |
| 2022-12-31 | $322.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $619.00K derived: sum of 2 quarters · filed 2024-02-22 | $863.00K derived: sum of 3 quarters · filed 2024-02-22 | $1.19M 10-K · filed 2024-02-22 |
| 2022-09-30 | $297.00K 10-Q · filed 2023-11-02 | $541.00K derived: sum of 2 quarters · filed 2023-11-02 | $870.00K 10-Q · filed 2023-11-02 | $1.14M derived: sum of 4 quarters · filed 2023-11-02 |
| 2022-06-30 | $244.00K 10-Q · filed 2023-08-03 | $573.00K 10-Q · filed 2023-08-03 | $845.00K derived: sum of 3 quarters · filed 2023-08-03 | $1.20M derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | $329.00K 10-Q · filed 2023-05-04 | $601.00K derived: sum of 2 quarters · filed 2023-05-04 | $959.00K derived: sum of 3 quarters · filed 2023-05-04 | $1.11M derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | $272.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $630.00K derived: sum of 2 quarters · filed 2023-02-23 | $783.00K derived: sum of 3 quarters · filed 2023-02-23 | $1.01M 10-K · filed 2023-02-23 |
| 2021-09-30 | $358.00K 10-Q · filed 2022-11-03 | $511.00K derived: sum of 2 quarters · filed 2022-11-03 | $743.00K 10-Q · filed 2022-11-03 | $933.00K derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | $153.00K 10-Q · filed 2022-08-09 | $385.00K 10-Q · filed 2022-08-09 | $575.00K derived: sum of 3 quarters · filed 2022-08-09 | $791.00K derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $232.00K 10-Q · filed 2022-05-03 | $422.00K derived: sum of 2 quarters · filed 2022-05-03 | $638.00K derived: sum of 3 quarters · filed 2022-05-03 | $732.00K derived: sum of 4 quarters · filed 2022-05-03 |
| 2020-12-31 | $190.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $406.00K derived: sum of 2 quarters · filed 2022-02-24 | $500.00K derived: sum of 3 quarters · filed 2022-02-24 | $621.00K 10-K · filed 2022-02-24 |
| 2020-09-30 | $216.00K 10-Q · filed 2021-11-10 | $310.00K derived: sum of 2 quarters · filed 2021-11-10 | $431.00K 10-Q · filed 2021-11-10 | $471.00K derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $94.00K 10-Q · filed 2021-08-06 | $201.00K 10-Q · filed 2021-08-06 | $255.00K derived: sum of 3 quarters · filed 2021-08-06 | $358.00K derived: sum of 4 quarters · filed 2021-08-06 |
| 2020-03-31 | $107.00K 10-Q · filed 2021-05-06 | $161.00K derived: sum of 2 quarters · filed 2021-05-06 | $264.00K derived: sum of 3 quarters · filed 2021-05-06 | |
| 2019-12-31 | $54.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $157.00K derived: sum of 2 quarters · filed 2021-03-11 | $340.00K 10-K · filed 2021-03-11 | |
| 2019-09-30 | $103.00K 10-Q · filed 2020-11-05 | $286.00K 10-Q · filed 2020-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |